http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011142620-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afd115dec46c157d3739020ebd4d866b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_31d6f6ed6d87ed8e890bb5012c4d583a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6726cb02fbe557c148bcac2bf223224
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_86c1ca95265b842830961863a01555f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_193d2ff4cd7dd3d1ede6719d1569201e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5386
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5386
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-08
filingDate 2011-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f73f1eb7f2a19dab6bd7feb00f3f7d16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_459f99b2db21280613070f94e40c3443
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca45f5f030224f5d65c1e82181f1837b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f8117c796d52068412ba9fb637ae00f
publicationDate 2012-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2011142620-A3
titleOfInvention (+)-3-hydroxymorphinan-based polycycle derivatives as neuroprotectants
abstract A (+)-3-hydroxymorphinan-based polycycle derivative of formula (I) is effective as a neuroprotective agent for neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, and ischemic stroke.
priorityDate 2010-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009203723-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006063792-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008234307-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5463854
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412374
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419496124

Total number of triples: 33.